Medical & Pharma Meetings

In 2013, GSK stopped doing it. In 2019, GSK is back at it. Over that time, though, other firms that never stopped doing it managed to tweak the practice in positive ways.

A healthcare-meeting compliance expert makes the case for globalizing your regulatory knowledge.

As the medical/pharma industry changes rapidly, the education and networking avenues for healthcare providers and researchers must adapt as well. Chris Wehking leads those change initiatives in the field of anesthesiology.